#Biocon, the Global Biopharmaceuticals Company of #India, on Friday Said Its #Q2FY22 ... - Latest Tweet by IANS India
The latest Tweet by IANS India states, '#Biocon, the global biopharmaceuticals company of #India, on Friday said its #Q2FY22 revenue growth was up by 10 per cent at Rs 1,945 crore, primarily driven by good performance of the Research Services and Biosimilars business segments.'